NEWS

A perfect example of a persistent hypoglossal artery...

The Bow Hunter Syndrome

Tiger 13 Stentectomy

Transorbital endovascular embolization of a dural CCF

Treating a recurrence of Acom aneurysm using flow diversion

CERENOVUS Launches NIMBUS™ Geometric Clot Extractor to Remove Tough Clots

IRVINE, CA – October 7, 2020 – CERENOVUS, part of Johnson & Johnson Medical Devices Companies*, today announced the European launch of CERENOVUS NIMBUS™, designed to remove tough clots for successful revascularization in patients with acute ischemic stroke caused by a large vessel occlusion.

Dural AVF with sequestrated sinus refluxing into cortical vein

Mechanical thrombectomy and giant fusiform aneurysm history

MicroVention-Terumo announces new leadership: the company appoints new P...

Aliso Viejo, CA. – September 22, 2020 –MicroVention, Inc., a U.S. based subsidiary of Terumo and leading global neurovascular company, announced today the appointment of a new President and CEO, Mr. Carsten Schroeder. The MicroVention acting President and CEO, Kazuaki Kitabatake, who has been in his role since August 2019, will continue as Chairman of the Board for MicroVention.  Mr. Schroeder will assume this position with MicroVention in early November 2020. 

Embolization with two braided stents in "X"